Navigation Links
Star Scientific Files First Quarter Report, Updates Details of Flint Study Using RCP-006
Date:5/11/2011

GLEN ALLEN, Va., May 11, 2011 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) filed its report on first-quarter 2011 yesterday with the Securities and Exchange Commission (SEC). The company reported first-quarter net sales totaling $156 thousand compared with $149 thousand for the same quarter in 2010. Sales of CigRx®, the dietary supplement developed by the Rock Creek Pharmaceuticals subsidiary and in test market since August 2010, contributed 29.5% of first-quarter sales.  The company also reported that CigRx sales have responded favorably to an expanded national test market that began in late February.

(Logo: http://photos.prnewswire.com/prnh/20090317/STARSCIENTIFICLOGO)

The company also reported a first-quarter net loss of approximately $6.1 million compared to a net loss of $4.8 million for first quarter 2010. The increase in the first-quarter net loss over the same period in 2010 is due primarily to a non-cash stock option expense of roughly $1.1 million.  Working capital as of March 31 totaled approximately $17.8 million, which included roughly $18.7 million in cash. Star Scientific entered into securities purchase and registration rights agreements with investors during the first quarter under which the company received proceeds of $11.0 million and proceeds of $1.0 million in April in connection with another purchase and registration agreement executed on March 30.

Star Scientific indicated that the Roskamp Institute is in the process of revising the planned Alzheimer's study using RCP-006, which the Institute announced in an October 7, 2010 release. This revision will significantly increase the size of the subject pool.

The company's Rock Creek Pharmaceuticals subsidiary also announced that the multi-site clinical trial, the Flint Study, is underway. The study is designed to determine the effect of RCP-006 on peripheral marke
'/>"/>

SOURCE Star Scientific, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Supports Asthma Awareness Month With Donation to Asthma Foundation
2. Boston Scientific Begins U.S. and International Launch of Expect™ Endoscopic Ultrasound Aspiration Needle
3. Boston Scientific Begins International Launch and First Implants of Next-Generation Devices to Treat Heart Failure and Sudden Cardiac Death
4. Boston Scientific Offers New CRT-D Warranty Program Covering Phrenic Nerve Stimulation
5. Boston Scientifics SpyGlass® Direct Visualization System Achieves Global Utilization Milestones
6. Stereotaxis Continued Leadership in Scientific Outcome Data Prominently Displayed with Multiple Key Presentations at HRS 2011
7. Boston Scientific Announces CE Mark Approval and First Use of Blazer™ Open-Irrigated Catheter in Europe
8. Boston Scientific Announces Its Schedule for Heart Rhythm Society Scientific Sessions
9. Rhythmia Medical Highlights Studies to be Presented at Heart Rhythm Society 2011 Annual Scientific Session
10. Boston Scientific Announces FDA Approval and U.S. Launch of ION™ Platinum Chromium Stent System
11. Boston Scientific Announces Results for First Quarter Ended March 31, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment ... Chief Executive Officer.  Mark was promoted from his current role ... company,s four facilities in Massachusetts , ... Tegra Medical in 2012 with 20+ years of broad-based operations, ...
(Date:1/15/2014)... Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), a ... a non-invasive, wireless continuous glucose monitoring system, today announced ... Interim CEO of Echo Therapeutics, will present at "TEN", ... Mr. Doman will make a corporate presentation ...
(Date:1/15/2014)... TORONTO , Jan. 15, 2014  According to ... medical technology market intelligence, the United ... occlusion (TEO) device markets will expand moderately through ... fastest-growing segments. In particular, increasing interest in drug-eluting ...
Breaking Medicine Technology:Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... to anti-clotting drug, CHICAGO, March 29 ... dose of a medication that prevents blood clotting,significantly ... coronary interventions (PCI), according to a multicenter study,reported ... the SCAI,Annual Scientific Sessions in Partnership with ACC ...
... ,culotte, technique better?, CHICAGO, March 29 When ... of two coronary arteries -- or a,bifurcation lesion -- ... vessels without blocking the opening to the side branch. ... on which of,two techniques produces the best long-term results ...
Cached Medicine Technology:Tailored Clopidogrel Dosing Improves PCI Outcomes 2Tailored Clopidogrel Dosing Improves PCI Outcomes 3Stenting Techniques Vie in Branchpoint Lesions 2
(Date:4/14/2014)... Doctors at Henry Ford Hospital reached a medical ... replacement using a novel way to access the heart. ... United States performing the unique procedure called transcaval valve ... blood vessels. , Northern Michigan resident Viola Waller, 80, ...
(Date:4/14/2014)... , , Penicillin, one of the scientific marvels of the ... it once won against bacterial infections. But scientists at ... new approach to restoring its combat effectiveness, even against ... the power of the penicillin family of drugs since ...
(Date:4/14/2014)... their radiation treatment decisions leaves cancer patients feeling more ... distress around the experience, researchers from the Perelman ... report in the journal Cancer . , In ... Neha Vapiwala, MD , an associate professor in the ...
(Date:4/14/2014)... Popular web information on colorectal cancer is too ... address the appropriate risks to and concerns of patients, ... , In a review of a dozen popular websites, ... cancer screening were written beyond the recommended sixth-grade reading ...
(Date:4/14/2014)... the molecule, called microRNA 135b, is a vital ,worker, ... growth of bowel cancers. , Drugs targeted at the ... mutations at once, while tests for it could identify ... , The research was carried out by an international ...
Breaking Medicine News(10 mins):Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:Shared decision making during radiation therapy improves patient satisfaction 2Health News:Shared decision making during radiation therapy improves patient satisfaction 3Health News:Website information on colon cancer too complex, fails to address key concerns 2Health News:Website information on colon cancer too complex, fails to address key concerns 3Health News:'MicroRNA' could be key target for bowel cancer treatment 2
... French . , Montreal, February 22, 2010 ... young immigrants. A new study published in the Journal ... children from multiethnic, disadvantaged, inner-city neighbourhoods are up to 3.5 ... an estimated 45,000 school-aged children immigrate to Canada with their ...
... URBANA - A University of Illinois researcher advises caution ... this country,s Latino adolescents and young adults. "When ... in a 90-minute program, the Latino students in my classes ... were right!" said Marcela Raffaelli, a U of I professor ...
... ... Boehringer Ingelheim (Canada) Ltd. , ... Toronto, Ontario, Canada (PRWEB) February 22, 2010 -- Dalton Pharma Services announces ... the agreement Dalton will continue to provide chemistry services in support of Boehringer,s pharmaceutical ...
... life, researchers say , MONDAY, Feb. 22 (HealthDay News) ... causes low energy levels and reduced quality of life, ... a new study suggests. , About 15 percent of ... late side effect of chemotherapy or radiation therapy. , ...
... ... ... ... ...
... , ... ... ... ...
Cached Medicine News:Health News:Are Latino teens sexual risk takers? It's complicated, researcher says 2Health News:Are Latino teens sexual risk takers? It's complicated, researcher says 3Health News:Dalton Pharma Services and Boehringer Ingelheim (Canada) Ltd. Announce the Renewal of their Chemistry Services Agreement 2Health News:Testicular Cancer Survivors May Have Hormone Deficiency 2Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 2Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 3Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 4Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 5Health News:Anshen + Allen Uses ArchiCAD to Transform Shipping Containers Into Clinics for the Developing World 6Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 2Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 3Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 4Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 5Health News:57 Year-Old Grandmother Travels to Atacama Desert to Run First of Four Ultramarathons for Charity 6
... , , The Shortyavailable with both Impact ... our face-to-face relationship with the scientific community generates ... pipetting easier and more effective., Shorter and ... Gets you closer to the working area ...
... Powerful and Flexible Impact And Impact2 Pipettors ... volume ranges, our single channel Impact and ... of any application. Engineered with the same ... multichannel line, these pipettors are equally easy ...
... And Impact2 Pipettors , , Available ... channel Impact and Impact2 pipettors can effectively ... with the same ergonomic design and superior ... are equally easy to program for a ...
... The Finnpipette BioControl is a ... technology. A complete liquid handling system ... twelve interchangeable tip cone modules. All ... tip cone modules fit one handle. ...
Medicine Products: